Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Iron showdown: pills or IV for new moms?

NCT ID NCT07340450

Disease control Sponsor: Shahida Islam Medical Complex Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two ways to treat anemia after childbirth: taking iron pills by mouth or getting iron through a vein. 122 women with postpartum anemia took part. The main goal was to see which method raised hemoglobin levels more effectively.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
iron (ferric carboxymaltose or ferrous sulfate)
What this could lead to
If it works, this could help doctors choose the best way to treat anemia after childbirth, improving recovery for new mothers.
What could go wrong
This is a small, completed trial with no phase, so results may not apply broadly. Individual responses to iron therapy can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

122 people

The number who actually took part.

Started

Feb 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. All women with postpartum anaemia as per operational definition i.e Haemoglobin \<11 g/dl at 24 hours after delivery (either caesarean or SVD). 2. Age 20-40 years. 3. BMI 19-25. 4. Pre-operative haemoglobin \>10 g/dl. 5. Both primiparous and multiparous. 6. Both primigravida and multigravida. \- Exclusion Criteria: 1. Iron Intolerance or previous history of allergy to iron 2. Parenteral Iron hypersensitivity 3. Patients with thalassemia 4. Indication of blood transfusion 5. Patients with bleeding/ clotting disorders 6. Patients with postpartum haemorrhage 7. Patients with chronic diseases.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postpartum anaemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postpartum anaemia

Contacts and locations

Locations

  • Shahida Islam Medical College and Hospital, Lodhran

    Lodhrān, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.